Jeffrey M. Dayno

CIK: 0001615993

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (20.0%)

Position reduction

Option Exercises (M)5 (33.3%)

Derivative conversions

Awards (A)4 (26.7%)

Compensation grants

Other (G, F, J, C, D, …)3 (20.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

HRMY

Harmony Biosciences Holdings, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (15 total)

HRMY
Harmony Biosciences Holdings, Inc.
Jan 25, 2026
Tax Payment(F)
Direct
5.7K shares at avg. $36.82$208K
HRMY
Harmony Biosciences Holdings, Inc.
Jan 25, 2026
Exercise(M)
Direct
13K shares-
HRMY
Harmony Biosciences Holdings, Inc.
Jan 24, 2026
Exercise(M)
Direct
10.5K shares-
HRMY
Harmony Biosciences Holdings, Inc.
Jan 24, 2026
Tax Payment(F)
Direct
4.8K shares at avg. $36.82$176K
HRMY
Harmony Biosciences Holdings, Inc.
Jan 22, 2026
Award(A)
Restricted Stock Units
Direct
52.9K shares-
HRMY
Harmony Biosciences Holdings, Inc.
Jan 22, 2026
Award(A)
Stock Option
Direct
184.6K shares-
HRMY
Harmony Biosciences Holdings, Inc.
Dec 12, 2025
Sale(S)
Direct
5.9K shares at avg. $40.11$238K
HRMY
Harmony Biosciences Holdings, Inc.
Dec 12, 2025
Exercise(M)
Direct
20K shares at avg. $8.22$164K
HRMY
Harmony Biosciences Holdings, Inc.
Dec 12, 2025
Sale(S)
Direct
20K shares at avg. $40.11$802K
HRMY
Harmony Biosciences Holdings, Inc.
Jan 25, 2025
Award(A)
Stock Option
Direct
180K shares-
HRMY
Harmony Biosciences Holdings, Inc.
Jan 25, 2025
Award(A)
Restricted Stock Units
Direct
52K shares-
HRMY
Harmony Biosciences Holdings, Inc.
Jan 24, 2025
Tax Payment(F)
Direct
4.6K shares at avg. $38.01$174K
HRMY
Harmony Biosciences Holdings, Inc.
Jan 24, 2025
Exercise(M)
Direct
10.5K shares-
HRMY
Harmony Biosciences Holdings, Inc.
Jan 21, 2025
Exercise(M)
Direct
19.3K shares at avg. $8.22$159K
HRMY
Harmony Biosciences Holdings, Inc.
Jan 21, 2025
Sale(S)
Direct
19.3K shares at avg. $40.13$774K

		Type	Shares	Price		Ownership
Jan 25, 2026	HRMY Harmony Biosciences Holdings, Inc.	Tax Payment(F)	5,654	$36.82	$208,180	Direct
Jan 25, 2026	HRMY Harmony Biosciences Holdings, Inc.	Exercise(M)	13,000	-	$0	Direct
Jan 24, 2026	HRMY Harmony Biosciences Holdings, Inc.	Exercise(M)	10,500	-	$0	Direct
Jan 24, 2026	HRMY Harmony Biosciences Holdings, Inc.	Tax Payment(F)	4,785	$36.82	$176,184	Direct
Jan 22, 2026	HRMY Harmony Biosciences Holdings, Inc.	Award(A) Restricted Stock Units	52,900	-	-	Direct
Jan 22, 2026	HRMY Harmony Biosciences Holdings, Inc.	Award(A) Stock Option	184,600	-	-	Direct
Dec 12, 2025	HRMY Harmony Biosciences Holdings, Inc.	Sale(S)	5,933	$40.11	$237,957	Direct
Dec 12, 2025	HRMY Harmony Biosciences Holdings, Inc.	Exercise(M)	20,000	$8.22	$164,400	Direct
Dec 12, 2025	HRMY Harmony Biosciences Holdings, Inc.	Sale(S)	20,000	$40.11	$802,146	Direct
Jan 25, 2025	HRMY Harmony Biosciences Holdings, Inc.	Award(A) Stock Option	180,000	-	-	Direct
Jan 25, 2025	HRMY Harmony Biosciences Holdings, Inc.	Award(A) Restricted Stock Units	52,000	-	-	Direct
Jan 24, 2025	HRMY Harmony Biosciences Holdings, Inc.	Tax Payment(F)	4,567	$38.01	$173,592	Direct
Jan 24, 2025	HRMY Harmony Biosciences Holdings, Inc.	Exercise(M)	10,500	-	$0	Direct
Jan 21, 2025	HRMY Harmony Biosciences Holdings, Inc.	Exercise(M)	19,293	$8.22	$158,588	Direct
Jan 21, 2025	HRMY Harmony Biosciences Holdings, Inc.	Sale(S)	19,293	$40.13	$774,245	Direct

1-15 of 15 transactions

About Dayno Jeffrey M.

Dayno Jeffrey M. (SEC CIK 0001615993) files insider reports with the SEC as PRESIDENT, CEO of Harmony Biosciences Holdings, Inc. (HRMY).

Signal8 holds 4 ownership filings by Dayno Jeffrey M., all Form 4s, filed between Jan 23, 2025 and Jan 26, 2026. Those filings report 15 transactions, from Jan 21, 2025 to Jan 25, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Dayno Jeffrey M.'s filings is in PLYMOUTH MEETING, PA.

Recent filings by Dayno Jeffrey M.

Jan 25, 2026: Tax withholding of HRMY shares (Form 4, code F).
Jan 25, 2026: Option exercise of HRMY shares (Form 4, code M).
Jan 24, 2026: Option exercise of HRMY shares (Form 4, code M).
Jan 24, 2026: Tax withholding of HRMY shares (Form 4, code F).
Jan 22, 2026: Grants or awards of HRMY derivative securities (2 lines, Form 4, code A).

Other insiders filing for Harmony Biosciences Holdings, Inc. (HRMY)

Budur Kumar, CHIEF MEDICAL OFFICER
Mollichella Stephen M., INT PRINCIAL FINANCIAL OFFICER
Germano Geno J, Director
Szyper Linda M, Director
Philip Ron M, Director
Graf R. Mark, Director

How to read Form 4 transaction codes